| Structure |
Chemical Name |
CAS |
MF |
 |
R-Tirofiban |
158808-86-7 |
C22H36N2O5S |
 |
Canagliflozin Impurity 20 |
|
|
 |
Canagliflozin Impurity 6 |
|
|
 |
Carfilzomib Impurity 6 |
|
|
 |
Daclatasvir Impurity 5 (SRSS-Isomer) |
1009117-28-5 |
C40H50N8O6 |
 |
Dolutegravir Impurity 7 |
2244161-71-3 |
C20H21N3O5 |
 |
Istradefylline Impurity F |
|
|
 |
Linagliptin Impurity 22 |
|
|
 |
Nintedanib impurity G |
894783-61-0 |
C30H31N5O4 |
![3,3′-[(2-methylbenzene-1,3-diyl)bis(oxy)]bis(N-methyl- 3-phenylpropan-1-amine)](/CAS/20211123/GIF/1010818-93-5.gif) |
3,3′-[(2-methylbenzene-1,3-diyl)bis(oxy)]bis(N-methyl- 3-phenylpropan-1-amine) |
1010818-93-5 |
C27H34N2O2 |
 |
Febuxostat impurity 36 |
1805770-40-4 |
C12H12N2O |
![N-[1-[(3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]- 2-Propenamide](/CAS/20180601/GIF/2031255-27-1.gif) |
N-[1-[(3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]- 2-Propenamide |
2031255-27-1 |
C28H26N6O3 |
 |
4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
|
C8H11FN3O4S- |
 |
Anastrozole Impurity 3 |
|
|
 |
Cephalexin Impurity 4 |
|
C16H17N3O4S |
 |
Rivaroxaban Impurity 42 |
|
|
 |
(R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoic acid |
1422514-05-3 |
C22H26FN3O6S |
 |
Atorvastatin 2-Fluoro t-Butyl Ester |
1099474-28-8 |
C40H47FN2O5 |
 |
Cabozantinib Impurity C |
|
|
 |
(3R,4R)-N,4-dimethyl-piperidin-3-amine |
1354469-76-3 |
C7H16N2 |
![4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine](/CAS/20180601/GIF/952518-97-7.gif) |
4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine |
952518-97-7 |
C9H7N5 |
 |
5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde |
881676-90-0 |
C16H12N2O3S |
 |
3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4R)- |
100332-12-5 |
C13H18FNO |
 |
r-Cytidine |
13913-16-1 |
C9H13N3O5 |
 |
Pyridine, 4-chloro-2-(chloromethyl)-3-methyl- |
168167-48-4 |
C7H7Cl2N |
 |
1,2,4-Triazolo(3,4-b)benzothiazole-5-methanol |
69243-49-8 |
C9H7N3OS |
 |
Benzoicacid, 2-sulfino- |
13165-80-5 |
C7H6O4S |
 |
Benzenemethanamine, a-ethyl-N,N-dimethyl- |
3330-05-0 |
C11H17N |
 |
CIS-1,2-BIS(AMINOMETHYL)CYCLOBUTANE |
15286-88-1 |
C6H14N2 |
 |
N-FORMYL-1-(2-AMINO-1-(4-METHOXYPHENYL)ETHYL)CYCLOHEXANOL |
272788-07-5 |
C16H23NO3 |
 |
Acotiamide Impurity |
198470-83-6 |
C20H21N2NaO4S |
 |
Terbutaline Impurity |
52144-90-8 |
C26H29NO3 |
![methyl (41S,12R,13aR)-13a-ethyl-12-
hydroxy-2,3,41,5,6,12,13,13aoctahydro-
1H-indolo[3,2,1-
de]pyrido[3,2,1-ij][1,5]naphthyridine-
12-carboxylate](/CAS/20210111/GIF/83508-83-2.gif) |
methyl (41S,12R,13aR)-13a-ethyl-12-
hydroxy-2,3,41,5,6,12,13,13aoctahydro-
1H-indolo[3,2,1-
de]pyrido[3,2,1-ij][1,5]naphthyridine-
12-carboxylate |
83508-83-2 |
C21H26N2O3 |
 |
ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate |
473465-11-1 |
C18H18N2O3S |
 |
Ropivacaine-iPr-R |
1050482-18-2 |
C17H26N2O |
 |
Demiditraz IMpurity |
944268-66-0 |
C20H22N2O |
 |
AcarBose EP Impurity B |
1220983-54-9 |
C26H43NO17 |
 |
Alogliptin Impurity 17 |
|
|
 |
Aprepitant Impurity 15 |
1447693-83-5 |
C20H19ClF7NO2 |
 |
Betamethasone EP Impurity H |
185613-71-2 |
C22H29FO5 |
 |
Blonanserin Impurity 10 |
132810-87-8 |
C23H30ClN3 |
 |
Blonanserin impurity G |
|
|
 |
Cefodizime Impurity 5 |
|
|
 |
Clindamycin Impurity 4 |
|
|
 |
Doxofylline Impurity 4 |
2095554-12-2 |
C11H16N4O5 |
 |
Eltrombopag Impurity 1 |
1246929-02-1 |
C25H23N5O3 |
 |
Everolimus impurity A |
|
|
 |
Fosaprepitant Impurity 13 |
|
|
 |
Gefitinib Impurity J |
|
|
 |
Isavuconazole Impurity 23 |
|
|
 |
Isavuconazole Impurity 29 |
|
|
 |
Isavuconazole Impurity 7 |
|
|
 |
Lercanidipine Impurity 6 |
786625-22-7 |
C37H43N3O6 |
 |
Linagliptin Impurity 43 |
|
|
 |
HERBACETIN-3,8-DIGLUCOPYRANOSIDE |
99224-12-1 |
C27H30O17 |
 |
ACETAMINOPURINE |
6034-68-0 |
C7H7N5O |
 |
2-(4-HYDROXY-PHENYL)-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID |
886501-78-6 |
C11H9NO3S |
 |
MiraBegron Impurity A |
|
|
 |
Moxifloxacin Impurity 15 |
|
|
 |
Moxifloxacin Impurity 32 |
|
|
 |
Nifedipine Impurity F |
53055-15-5 |
C18H20N2O6 |
 |
Olaparib Impurity 15 |
2250243-17-3 |
C24H25FN4O3 |
 |
Olopatadine Impurity 4 |
55690-15-8 |
C18H18O5 |
 |
Posaconazole Impurity 26 |
|
|
 |
Posaconazole Impurity 48 |
1902954-03-3 |
C37H42F2N8O5 |
 |
Posaconazole Impurity 9 |
|
|
 |
Roxithromycin Impurity E |
|
|
 |
SofosBuvir impurity 48 |
|
|
 |
SofosBuvir Impurity 54 |
1431932-81-8 |
C12H17ClNO4P |
 |
Timolol EP Impurity G |
75202-36-7 |
C6H9N3O3S |
 |
Tofacitinib Impurity 44 |
2374700-39-5 |
C13H19N5 |
 |
Trelagliptin Impurity 24 |
|
|
 |
dimethyl 3- isobutylpentanedioate |
145328-03-6 |
C11H20O4 |
![Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]-](/CAS/20180601/GIF/1408077-50-8.gif) |
Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]- |
1408077-50-8 |
C15H15ClO2 |
![2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one](/CAS/20180601/GIF/1984788-96-6.gif) |
2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one |
1984788-96-6 |
C12H15N5O4 |
 |
Ampicillin Impurity C |
|
|
 |
Ampicillin Impurity O |
|
|
 |
mixture of PD 312236 and PD 312237 |
|
|
 |
Axitinib Impurity 27 |
1639137-80-6 |
C24H20N4O2S |
![(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate](/CAS/20180601/GIF/104873-15-6.gif) |
(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate |
104873-15-6 |
C17H18N2O7 |
 |
Lesinurad Impurity |
|
|
 |
Chrysophanol triglucoside |
120181-07-9 |
C33H40O19 |
![7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl-](/CAS/20180601/GIF/1829588-57-9.gif) |
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl- |
1829588-57-9 |
C17H19ClN4O2 |
 |
Cefminox sodium impurities Ⅲ |
|
|
 |
Canagliflozin Impurity 18 |
1951467-29-0 |
C24H25FO6S |
 |
Fosaprepitant Impurity 6 |
327623-34-7 |
C21H19F6NO3 |
 |
Ivabradine Impurity 16 HCl |
304464-98-0 |
C26H34N2O5 |
 |
Moxifloxacin EP Impurity A HCl |
|
|
 |
Paroxetine EP Impurity H HCl |
503834-41-1 |
C19H23ClFNO |
 |
Solifenacin Related Compound 13 |
1251905-45-9 |
C17H17NO2 |
![1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide](/CAS/20180601/GIF/2101651-50-5.gif) |
1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide |
2101651-50-5 |
C14H12FN5 |
 |
N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide |
152504-12-6 |
C22H31ClN10 |
 |
Ethylmethyl-carbamic chloride |
42252-34-6 |
C4H8ClNO |
![N-(3-{[(4-methylphenyl)sulfonyl]amino}phenyl)acetamide](/CAS/20180601/GIF/329941-39-1.gif) |
N-(3-{[(4-methylphenyl)sulfonyl]amino}phenyl)acetamide |
329941-39-1 |
C15H16N2O3S |
 |
Cisatracurium-20-methyl Dibenzenesulfonate |
1193104-85-6 |
C60H79N2O15S+ |
![[R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE](/CAS/GIF/128311-06-8.gif) |
[R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE |
128311-06-8 |
C15H24Cl2N2 |
 |
GURKHSYORGJETM-MGDILKBHSA-N |
1992961-26-8 |
C33H39ClN4O6 |
 |
Despropoxy Ethoxy Udenafil |
268204-07-5 |
C24H34N6O4S |
 |
DVCUGHHGLKCBMT-QVDQXJPCSA-N |
1356353-76-8 |
C15H24N6O6 |
 |
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |